Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A B Moser

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Annals of Neurology|April 20, 2001
Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screeningL Bezman, A B Moser, G V Raymond, et al.
Nature Medicine|November 11, 1998
Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophyS Kemp, H M Wei, J F Lu, et al.
Journal of Neuropathology and Experimental Neurology|October 9, 2001
Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentationM Ito, B M Blumberg, D J Mock, et al.
The Journal of Pediatrics|July 1, 1995
Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groupsA B Moser, M Rasmussen, S Naidu, et al.
American Journal of Medical Genetics|April 1, 1986
Neonatal adrenoleukodystrophy: new cases, biochemical studies, and differentiation from Zellweger and related peroxisomal polydystrophy syndromesR I Kelley, N S Datta, W B Dobyns, et al.
Annals of Neurology|March 23, 2001
Neurological and neuropathologic heterogeneity in two brothers with cobalamin C deficiencyJ M Powers, D S Rosenblatt, R E Schmidt, et al.
Journal of Inherited Metabolic Disease|January 1, 1992
Adrenoleukodystrophy: phenotypic variability and implications for therapyH W Moser, A B Moser, K D Smith, et al.
Neurology|September 1, 2010
Docosahexaenoic acid therapy in peroxisomal diseases: results of a double-blind, randomized trialA M Paker, J S Sunness, N H Brereton, et al.
Journal of Inherited Metabolic Disease|January 1, 1994
Cytosolic compartmentalization of hepatic alanine:glyoxylate aminotransferase in patients with aberrant peroxisomal biogenesis and its effect on oxalate metabolismC J Danpure, P Fryer, S Griffiths, et al.
Human Pathology|June 1, 1985
Fetal cerebrohepatorenal (Zellweger) syndrome: dysmorphic, radiologic, biochemical, and pathologic findings in four affected fetusesJ M Powers, H W Moser, A B Moser, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Annals of Neurology|April 20, 2001
Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screeningL Bezman, A B Moser, G V Raymond, et al.
Nature Medicine|November 11, 1998
Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophyS Kemp, H M Wei, J F Lu, et al.
Journal of Neuropathology and Experimental Neurology|October 9, 2001
Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentationM Ito, B M Blumberg, D J Mock, et al.
The Journal of Pediatrics|July 1, 1995
Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groupsA B Moser, M Rasmussen, S Naidu, et al.
American Journal of Medical Genetics|April 1, 1986
Neonatal adrenoleukodystrophy: new cases, biochemical studies, and differentiation from Zellweger and related peroxisomal polydystrophy syndromesR I Kelley, N S Datta, W B Dobyns, et al.
Annals of Neurology|March 23, 2001
Neurological and neuropathologic heterogeneity in two brothers with cobalamin C deficiencyJ M Powers, D S Rosenblatt, R E Schmidt, et al.
Journal of Inherited Metabolic Disease|January 1, 1992
Adrenoleukodystrophy: phenotypic variability and implications for therapyH W Moser, A B Moser, K D Smith, et al.
Neurology|September 1, 2010
Docosahexaenoic acid therapy in peroxisomal diseases: results of a double-blind, randomized trialA M Paker, J S Sunness, N H Brereton, et al.
Journal of Inherited Metabolic Disease|January 1, 1994
Cytosolic compartmentalization of hepatic alanine:glyoxylate aminotransferase in patients with aberrant peroxisomal biogenesis and its effect on oxalate metabolismC J Danpure, P Fryer, S Griffiths, et al.
Human Pathology|June 1, 1985
Fetal cerebrohepatorenal (Zellweger) syndrome: dysmorphic, radiologic, biochemical, and pathologic findings in four affected fetusesJ M Powers, H W Moser, A B Moser, et al.
Pageof 9